The use of a conjugate of a compound having a cytotoxic effect on cancer cells with glucose or another sugar allows for its increased uptake by a cancer cell, which is associated with increased expression of GLUT1 and a high rate of glycolysis. The gene discussed is SLC2A1; the disease is cancer.